214 related articles for article (PubMed ID: 38157849)
1. A short history of pluripotent stem cells markers.
Andrews PW; Gokhale PJ
Stem Cell Reports; 2024 Jan; 19(1):1-10. PubMed ID: 38157849
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and Molecular Characterization of Domestic Cat (Felis catus) Spermatogonial Stem Cells.
Powell RH; Galiguis J; Biancardi MN; Pope CE; Leibo SP; Wang G; Gómez MC
Biol Reprod; 2016 Jul; 95(1):20. PubMed ID: 27281702
[TBL] [Abstract][Full Text] [Related]
3. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
4. Expression of pluripotent stem cell markers in the human fetal testis.
Kerr CL; Hill CM; Blumenthal PD; Gearhart JD
Stem Cells; 2008 Feb; 26(2):412-21. PubMed ID: 18024420
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterisation of the early differentiating cells in neural differentiation of human embryonic stem cells.
Noisa P; Ramasamy TS; Lamont FR; Yu JS; Sheldon MJ; Russell A; Jin X; Cui W
PLoS One; 2012; 7(5):e37129. PubMed ID: 22615918
[TBL] [Abstract][Full Text] [Related]
6. Pluripotent Conversion of Muscle Stem Cells Without Reprogramming Factors or Small Molecules.
Bose B; Shenoy P S
Stem Cell Rev Rep; 2016 Feb; 12(1):73-89. PubMed ID: 26358783
[TBL] [Abstract][Full Text] [Related]
7. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
[TBL] [Abstract][Full Text] [Related]
8. Demarcation of stable subpopulations within the pluripotent hESC compartment.
Bhatia S; Pilquil C; Roth-Albin I; Draper JS
PLoS One; 2013; 8(2):e57276. PubMed ID: 23437358
[TBL] [Abstract][Full Text] [Related]
9. Quantitative comparison of stem cell marker-positive cells in fetal and term human amnion.
Izumi M; Pazin BJ; Minervini CF; Gerlach J; Ross MA; Stolz DB; Turner ME; Thompson RL; Miki T
J Reprod Immunol; 2009 Jul; 81(1):39-43. PubMed ID: 19501410
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of bone marrow-derived stage-specific embryonic antigen 1 positive pluripotent stem cells into male germ cells.
Shirazi R; Zarnani AH; Soleimani M; Nayernia K; Ragerdi Kashani I
Microsc Res Tech; 2017 Apr; 80(4):430-440. PubMed ID: 27990704
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in expression of specific markers for human embryonic stem cells.
Laursen SB; Møllgård K; Olesen C; Oliveri RS; Brøchner CB; Byskov AG; Andersen AN; Høyer PE; Tommerup N; Yding Andersen C
Reprod Biomed Online; 2007 Jul; 15(1):89-98. PubMed ID: 17623545
[TBL] [Abstract][Full Text] [Related]
12. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.
Moschidou D; Mukherjee S; Blundell MP; Jones GN; Atala AJ; Thrasher AJ; Fisk NM; De Coppi P; Guillot PV
Stem Cells Dev; 2013 Feb; 22(3):444-58. PubMed ID: 23050522
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
[TBL] [Abstract][Full Text] [Related]
14. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.
Park JK; Kim HS; Uh KJ; Choi KH; Kim HM; Lee T; Yang BC; Kim HJ; Ka HH; Kim H; Lee CK
PLoS One; 2013; 8(1):e52481. PubMed ID: 23326334
[TBL] [Abstract][Full Text] [Related]
15. Oct4 expression in in-vitro-produced sheep blastocysts and embryonic-stem-like cells.
Sanna D; Sanna A; Mara L; Pilichi S; Mastinu A; Chessa F; Pani L; Dattena M
Cell Biol Int; 2009 Dec; 34(1):53-60. PubMed ID: 19947952
[TBL] [Abstract][Full Text] [Related]
16. New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells.
O'Brien CM; Chy HS; Zhou Q; Blumenfeld S; Lambshead JW; Liu X; Kie J; Capaldo BD; Chung TL; Adams TE; Phan T; Bentley JD; McKinstry WJ; Oliva K; McMurrick PJ; Wang YC; Rossello FJ; Lindeman GJ; Chen D; Jarde T; Clark AT; Abud HE; Visvader JE; Nefzger CM; Polo JM; Loring JF; Laslett AL
Stem Cells; 2017 Mar; 35(3):626-640. PubMed ID: 28009074
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
[TBL] [Abstract][Full Text] [Related]
18. Role of Oct4 in maintaining and regaining stem cell pluripotency.
Shi G; Jin Y
Stem Cell Res Ther; 2010 Dec; 1(5):39. PubMed ID: 21156086
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Trypsin Treatment Promotes Stem Cell Potency of Canine Adipose-Derived Mesenchymal Stem Cells.
Mitani K; Ito Y; Takene Y; Hatoya S; Sugiura K; Inaba T
Stem Cells Dev; 2021 Mar; 30(6):337-349. PubMed ID: 33528297
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Esg1 expression in pluripotent cells and the germline reveals similarities with Oct4 and Sox2 and differences between human pluripotent cell lines.
Western P; Maldonado-Saldivia J; van den Bergen J; Hajkova P; Saitou M; Barton S; Surani MA
Stem Cells; 2005; 23(10):1436-42. PubMed ID: 16166252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
